Site-Overview.com
 

Websites using e-prescribing as a keyword

Here you can see a list of websites which are using e-prescribing as keyword according to our database.

 
Websites found: 139
Number of websited displayed: 85
 

Queries in the same category:

 

List of results:

Plaque Psoriasis & Psoriatic Arthritis | STELARA® (ustekinumab)
http://site-overview.com/stats/stelarainfo.com
Learn about moderate to severe plaque psoriasis & active psoriatic arthritis treatment STELARA®. See Full Prescribing Info & Important Safety Information.
  • Google Analytics ID: 1863405-87
  • Website Address renewal date: 17/5/13
  • Domain Address Reg. date: 08/12/4
  • Website address in use until: 17/12/4
Electronic Prior Authorization | CenterX | CenterX is a comprehensive e-prescribing network offering electronic prior authorization
http://site-overview.com/stats/centerx.com
CenterX is a comprehensive e-prescribing directory service.
  • Google+ Identity: +CenterX1
  • Google Analytics ID: 33831230-1
  • Website Address renewal date: 16/9/21
  • Domain Address Reg. date: 05/11/13
  • Website address in use until: 17/11/13
Ophthalmology EMR Or EHR | Ophthalmic Computer Solution | Retina+ EMR
http://site-overview.com/stats/hcit-emr.com
If you are looking for document management software as well as ophthalmology emr or ehr, ambulatory surgery center emr or ehr and e-prescribing, please review our website. If you are also looking for an ophthalmic computer solution as well as retina+ emr, please review our website.
  • Google Analytics ID: 10032509-1
  • Website Address renewal date: 17/11/21
  • Domain Address Reg. date: 03/11/26
  • Website address in use until: 18/11/26
Tresiba® Long-Acting Insulin | Tresiba® (insulin degludec injection 100 Units/mL, 200 Units/mL)
http://site-overview.com/stats/tresiba.com
Once-daily Tresiba® is a long-acting insulin used to control high blood sugar in adults and children as young as 1 year old with diabetes. Read important safety and prescribing info on this page.
  • Website Address renewal date: 15/9/24
  • Domain Address Reg. date: 10/8/27
  • Website address in use until: 17/8/27
VELCADE® (bortezomib) Official Website
http://site-overview.com/stats/velcade.com
The Official Website for VELCADE® (bortezomib).
  • Google Analytics ID: 7032150-3
  • Website Address renewal date: 17/3/14
  • Domain Address Reg. date: 02/3/18
  • Website address in use until: 18/3/18
CINQAIR.com – CINQAIR® (reslizumab) Injection now approved
http://site-overview.com/stats/cinqair.com
CINQAIR® (reslizumab) Injection is now approved as an add-on treatment for adults (18 years and older) with severe asthma and elevated eosinophil levels
  • Google Analytics ID: 75273706-1
  • Website Address renewal date: 17/11/9
  • Domain Address Reg. date: 14/11/14
  • Website address in use until: 18/11/14
Patient Information DEXILANT (dexlansoprazole)
http://site-overview.com/stats/dexilant.com
Product information on treatment with DEXILANT (dexlansoprazole) and resources to help you understand and manage your condition. See full safety and prescribing information.
  • Google Analytics ID: 5448303-4
  • Website Address renewal date: 16/11/16
  • Domain Address Reg. date: 10/2/10
  • Website address in use until: 18/2/10
Biosimilar is not the same as REMICADE® (infliximab)
http://site-overview.com/stats/finelytuned.com
Learn about staying on REMICADE® (infliximab) if asked to consider a switch to a biosimilar. See full Prescribing & Safety info.
  • Website Address renewal date: 17/3/6
  • Domain Address Reg. date: 02/5/10
  • Website address in use until: 18/5/10
ACC/AHA ASCVD Risk Calculator
http://site-overview.com/stats/cvriskcalculator.com
Calculates ASCVD risk for heart disease and stroke using the 2013 ACC/AHA guidelines. Also incorporates JNC-8 blood pressure guidelines and USPSTF aspirin prescribing guidelines.
  • Google Analytics ID: 25772485-3
  • Website Address renewal date: 16/11/18
  • Domain Address Reg. date: 13/11/17
  • Website address in use until: 17/11/17
NICPLD: Welcome
http://site-overview.com/stats/nicpld.org
The Northern Ireland Centre for Pharmacy Learning and Development provides over 1,000 hours of learning opportunity each year to pharmacists, pre-registration trainees and pharmacy technicians.
  • Website Address renewal date: 13/3/21
  • Domain Address Reg. date: 08/5/30
  • Website address in use until: 18/5/30
Patient Information | ROZEREM (ramelteon)
http://site-overview.com/stats/rozerem.com
ROZEREM (ramelteon) is approved for adults having trouble falling asleep from insomnia. Ask your doctor about ROZEREM. See Important Safety Information and Prescribing Information.
  • Google Analytics ID: 5275299-2
  • Website Address renewal date: 17/10/11
  • Domain Address Reg. date: 05/2/25
  • Website address in use until: 19/2/25
SRS Pharmacy Systems
http://site-overview.com/stats/srspharmacy.com
SRS Pharmacy Systems is an integrated, EPCS certified, Pharmacy Management software and systems provider servicing pharmacies throughout the United States.
  • Google Analytics ID: 69032028-1
  • Website Address renewal date: 16/1/14
  • Domain Address Reg. date: 03/1/20
  • Website address in use until: 19/1/20
Interactive Health Partner � Health and Fitness Management
http://site-overview.com/stats/interactivehealthpartner.com
The Interactive Health Partner is a comprehensive set of health management tools for prescribing, tracking, and monitoring members' health & fitness activity.
  • Website Address renewal date: 17/3/4
  • Domain Address Reg. date: 07/1/4
  • Website address in use until: 18/1/4
Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma | VALCHLOR (mechlorethamine)
http://site-overview.com/stats/valchlor.com
Information for patients about an FDA-approved topical prescription medicine for Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma. Find important safety information medication guide and prescribing information.
  • Google Analytics ID: 55588032-1
  • Website Address renewal date: 16/10/21
  • Domain Address Reg. date: 11/10/25
  • Website address in use until: 17/10/25
e-Prescribing Software: MDToolbox
http://site-overview.com/stats/mdtoolbox.com
MDToolbox e-Prescribing software is designed to easily integrate with EHRs/EMRs/PMs. Add a Surescripts, Meaningful Use and EPCS Certified eRx module into your system with ease.
  • Google+ Identity: +MdtoolboxRx
  • Google Analytics ID: 31829479-1
  • Website Address renewal date: 17/5/7
  • Domain Address Reg. date: 11/5/6
  • Website address in use until: 19/5/6
Type 2 Diabetes Therapy | Welchol® (colesevelam HCI)
http://site-overview.com/stats/welchol.com
Discover Welchol®, which may help patients with type 2 diabetes lower high blood sugar and “bad” cholesterol levels. See Safety & Prescribing Information.
  • Website Address renewal date: 12/7/13
  • Domain Address Reg. date: 00/2/2
  • Website address in use until: 18/2/2
VIEKIRA XR™ (dasabuvir, ombitasvir, paritaprevir, and ritonavir) extended-release tablets
http://site-overview.com/stats/viekira.com
Official Site from AbbVie Inc. Please see prescribing information for more about the uses, benefits, and risks of VIEKIRA XR™.
  • Website Address renewal date: 17/7/19
  • Domain Address Reg. date: 13/8/20
  • Website address in use until: 18/8/20
Teeth Grinding Bruxism Cure | BruxRelief
http://site-overview.com/stats/teethgrindingbruxism.com
Do You Or Anyone You Know Wake Up Each Day With A Sore Jaw? Are You Grinding Away Your Teeth? Is Your Dentist Prescribing Costly Mouth Guards To Protect Your Teeth But You Continue Suffering From The Pain? We've Invented A CURE For Bruxism (Teeth Grinding) Which Affects 1 Out Of 10 Adults. But We Need Your Help To Launch Our Product.
  • Google Analytics ID: 51074959-1
  • Website Address renewal date: 18/2/1
  • Domain Address Reg. date: 17/1/31
  • Website address in use until: 19/1/31
Levemir® (insulin detemir [rDNA origin] injection) HCP Website
http://site-overview.com/stats/levemirpro.com
See information about basal insulin & the long-acting insulin from Levemir®. Read Important Safety & Prescribing Info from the Levemir® HCP Website.
  • Google Analytics ID: 44074826-2
  • Website Address renewal date: 16/11/1
  • Domain Address Reg. date: 10/10/28
  • Website address in use until: 18/10/28
Brisdelle® (paroxetine) non-hormonal medication for relief of hot flashes
http://site-overview.com/stats/brisdelle.com
Brisdelle® (paroxetine) is a non-hormonal medication indicated for the treatment of hot flashes in menopause. Read the full Prescribing Information, including Boxed WARNING.
  • Google Analytics ID: 86009080-1
  • Website Address renewal date: 16/10/2
  • Domain Address Reg. date: 13/4/5
  • Website address in use until: 20/4/5
Adempas (riociguat) - Official Site
http://site-overview.com/stats/adempas-us.com
Adempas (riociguat). Visit Adempas-US.com to see full safety and prescribing information including boxed warning. Learn about Adempas and the Aim Patient Support Program.
  • Website Address renewal date: 17/3/21
  • Domain Address Reg. date: 13/3/25
  • Website address in use until: 19/3/25
Complete Pharmacy Solutions & Best Pharmacy POS System|Myezpharmacy
http://site-overview.com/stats/myezpharmacy.org
Myezpharmacy provides complete pharmacy solutions with pharmacy POS system & 24 hour services for healthcare solutions with advanced technology that useful for physicians and pharmacist
  • Google+ Identity: +MyEzPharmacy
  • Google Analytics ID: 77199495-1
  • Website Address renewal date: 16/11/28
  • Domain Address Reg. date: 15/12/22
  • Website address in use until: 18/12/22
Patient | PRIALT® (ziconotide) intrathecal infusion
http://site-overview.com/stats/prialt.com
Visit the official site for PRIALT. See safety & Prescribing Information, including Warning about possible serious side effects.
  • Google Analytics ID: 6471724-15
  • Website Address renewal date: 17/7/1
  • Domain Address Reg. date: 00/2/17
  • Website address in use until: 19/2/17
e-Prescribing Integration and Software | DoseSpot
http://site-overview.com/stats/dosespot.com
The DoseSpot e-Prescribing platform is your company's prescription to e-Prescribing. Get Surescripts certified as quickly as possible.
  • Google Analytics ID: 46021048-1
  • Website Address renewal date: 15/8/12
  • Domain Address Reg. date: 07/9/10
  • Website address in use until: 18/9/10
Xiidra® (lifitegrast ophthalmic solution) 5% Official ECP Site
http://site-overview.com/stats/xiidra-ecp.com
Discover Xiidra® (lifitegrast ophthalmic solution) 5%, indicated to treat both the signs and symptoms of Dry Eye Disease. See Safety and Prescribing Info.
  • Website Address renewal date: 17/4/16
  • Domain Address Reg. date: 16/5/13
  • Website address in use until: 18/5/13
Official website | Collagenase SANTYL◊ Ointment
http://site-overview.com/stats/santyl.com
Official website for Collagenase SANTYL Ointment. See complete Safety and Prescribing Information on this page.
  • Website Address renewal date: 17/8/2
  • Domain Address Reg. date: 99/7/27
  • Website address in use until: 19/7/27
Homepage | SHINGRIX
http://site-overview.com/stats/shingrix.com
View the prescribing information for a newly approved vaccine called SHINGRIX and sign up to be the first to get the latest news and information.
  • Website Address renewal date: 17/10/23
  • Domain Address Reg. date: 08/2/27
  • Website address in use until: 18/2/27
E-Ordering Medical Equipment, Products & Services - Stratice Healthcare
http://site-overview.com/stats/edmeplus.net
Electronic ordering, referral and fulfillment of patients' medical equipment, products and care services. Electronic ordering, referral and fulfillment of home and durable medical equipment and supplies. Interoperable, EHR integrated and web-based electronic ordering and prescribing solutions.
  • Website Address renewal date: 17/7/24
  • Domain Address Reg. date: 14/7/23
  • Website address in use until: 18/7/23
ePrescribing Solutions | eazyScripts
http://site-overview.com/stats/eazyscripts.com
E-prescribing software doctors actually use.
  • Website Address renewal date: 17/8/10
  • Domain Address Reg. date: 14/10/9
  • Website address in use until: 22/10/9
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol For Health Care Professionals
http://site-overview.com/stats/symbicorttouchpoints.com
Official HCP site for SYMBICORT, an asthma and COPD treatment, providing information on the inhaler, side effects, dosage and prescribing information.
  • Website Address renewal date: 16/10/11
  • Domain Address Reg. date: 09/10/15
  • Website address in use until: 17/10/15
TNKase® Acute Myocardial Infarction Treatment
http://site-overview.com/stats/tnkase.com
Learn more about single-bolus TNKase® (tenecteplase) acute myocardial infarction treatment and the 5-second TNKase® dosing and administration. Indication For use in mortality reduction associated with acute myocardial infarction (AMI). Treatment should be initiated as soon as possible after the onset of AMI symptoms. Important Safety Information TNKase therapy in patients with acute myocardial infarction is contraindicated in the following certain situations (eg, active internal bleeding, history of cerebrovascular accident, known bleeding diathesis, severe uncontrolled hypertension) because of an increased risk of bleeding [See CONTRAINDICATIONS in full prescribing information]. The most common complication encountered during TNKase therapy is bleeding. Should serious bleeding (not controlled by local pressure) occur, any concomitant heparin or antiplatelet agents should be discontinued immediately. In certain conditions (eg, recent major surgery, cerebrovascular disease, hypertension) the risk of TNKase therapy may be increased and should be weighed against the anticipated benefits. [See WARNINGS in full prescribing information]. Cholesterol embolism has been reported rarely in patients treated with all types of thrombolytic agents; the true incidence is unknown. Coronary thrombolysis may result in arrhythmias associated with reperfusion. It is recommended that anti-arrhythmic therapy for bradycardia and/or ventricular irritability be available when TNKase is administered. Please see full Prescribing Information for additional important safety information.
  • Website Address renewal date: 16/10/24
  • Domain Address Reg. date: 00/3/13
  • Website address in use until: 18/3/13
NewCropRx | e-Prescribing | Home
http://site-overview.com/stats/newcroprx.com
NewCrop is an industry leading e-prescribing solution that has been deployed in a wide range of EHRs and medical networks since 2003.
  • Google Analytics ID: 72436120-1
  • Website Address renewal date: 15/9/13
  • Domain Address Reg. date: 03/11/12
  • Website address in use until: 18/11/12
Partial-Onset Seizure & PGTC (Grand Mal) Seizure Treatment | FYCOMPA
http://site-overview.com/stats/fycompa.com
Learn more about FYCOMPA, a treatment for partial-onset seizures and PGTC (grand mal) seizures. View Important Safety Information, Boxed Warning and Prescribing Information.
  • Website Address renewal date: 17/11/20
  • Domain Address Reg. date: 11/1/31
  • Website address in use until: 19/1/31
UTIBRON™ NEOHALER® (indacaterol and glycopyrrolate) | Home
http://site-overview.com/stats/utibron.com
Learn about UTIBRON™ NEOHALER® (indacaterol/glycopyrrolate), indicated for COPD treatment. See Full Prescribing and Safety Info & BOXED WARNING.
  • Website Address renewal date: 17/3/16
  • Domain Address Reg. date: 15/3/17
  • Website address in use until: 19/3/17
PrescQIPP
http://site-overview.com/stats/prescqipp.info
PrescQIPP - We are an NHS funded not-for-profit organisation that supports quality, optimised prescribing for patients. We produce evidence-based resources and tools for primary care commissioners, and provide a platform to share innovation across the NHS.
  • Google Analytics ID: 3367072-7
  • Website Address renewal date: 17/12/18
  • Domain Address Reg. date: 13/6/5
  • Website address in use until: 24/6/5
STIVARGA (regorafenib) | Patient Website
http://site-overview.com/stats/stivarga-us.com
Learn about STIVARGA (regorafenib). Visit STIVARGA-US.com to see full safety and prescribing information, including boxed warning.
  • Website Address renewal date: 15/6/3
  • Domain Address Reg. date: 12/6/6
  • Website address in use until: 17/6/6
DALVANCE® (dalbavancin) – Official Site
http://site-overview.com/stats/dalvance.com
Learn about DALVANCE® and how it can help change the ABSSSI treatment journey. See Full Prescribing & Safety Information.
  • Website Address renewal date: 17/4/8
  • Domain Address Reg. date: 13/5/9
  • Website address in use until: 19/5/9
EMR, Certified EHR, and Billing Software for Psychologists, Psychiatrists, and Mental Health
http://site-overview.com/stats/docutracinc.com
DocuTrac offers easy-to-use software for mental health, behavioral health, and substance abuse agencies including billing, e-prescribing, certified electronic health records, electronic medical records, and more
  • Google Analytics ID: 51903384-1
  • Website Address renewal date: 16/10/26
  • Domain Address Reg. date: 06/12/21
  • Website address in use until: 18/12/21
Janssen CarePath™ Patient Support Program | XARELTO® (rivaroxaban)
http://site-overview.com/stats/xareltocarepath.com
Register for the Janssen CarePath Support Program to find valuable cost and savings information. See full Prescribing & Safety Info including Boxed Warnings.
  • Google Analytics ID: 70816641-13
  • Website Address renewal date: 17/3/13
  • Domain Address Reg. date: 11/3/17
  • Website address in use until: 19/3/17
Official Site for ADVATE® [Antihemophilic Factor (Recombinant)]
http://site-overview.com/stats/advate.com
Learn about ADVATE. Please see the ADVATE Detailed Important Risk Information and full Prescribing Information.
  • Website Address renewal date: 16/9/1
  • Domain Address Reg. date: 02/6/3
  • Website address in use until: 24/6/3
INVEGA SUSTENNA® (paliperidone palmitate) for HCPs
http://site-overview.com/stats/invegasustennahcp.com
Find information for health care professionals about INVEGA® SUSTENNA®. See full safety and Prescribing Information, including boxed WARNING.
  • Google Analytics ID: 70816641-3
  • Website Address renewal date: 17/6/9
  • Domain Address Reg. date: 14/7/11
  • Website address in use until: 18/7/11
Prescribing Services Ltd
http://site-overview.com/stats/prescribingservices.org
  • Website Address renewal date: 17/8/26
  • Domain Address Reg. date: 06/8/26
  • Website address in use until: 18/8/26
BiDil (isosorbide dinitrate/hydralazine HCl) | Heart Failure Medication
http://site-overview.com/stats/bidil.com
BiDil is a prescription medicine used to treat heart failure (HF)… See important safety info & prescribing info.
  • Website Address renewal date: 17/1/23
  • Domain Address Reg. date: 02/3/24
  • Website address in use until: 19/3/24
PARAGARD® (intrauterine copper contraceptive) | Home
http://site-overview.com/stats/paragard.com
Learn about PARAGARD—the only hormone-free IUD that’s over 99% effective. It helps prevent pregnancy for up to 10 years, but your HCP can remove it at any time. Please see Important Safety Information and full Prescribing Information on this website.
  • Website Address renewal date: 16/12/6
  • Domain Address Reg. date: 97/12/12
  • Website address in use until: 17/12/11
Butrans® (buprenorphine) Transdermal System CIII | Official HCP Site
http://site-overview.com/stats/butrans.com
Discover Butrans, a Schedule III, extended-release opioid. See Full Prescribing Info, Safety Info & Boxed Warning.
  • Website Address renewal date: 16/6/9
  • Domain Address Reg. date: 03/7/10
  • Website address in use until: 18/7/10
SleepView® Web Portal
http://site-overview.com/stats/lucyme.com
Our HIPAA compliant and secure Web Portal offers prescribing physicians online access to patients' sleep test raw data, scoring by registered polysomnographic technologists, and professional interpretation with treatment recommendations by board-certified sleep physicians.
  • Website Address renewal date: 17/1/22
  • Domain Address Reg. date: 09/1/21
  • Website address in use until: 18/1/21
eHealthGlobal | Online Pharmacy | Health Care Mobility Solutions - eHealthGlobal
http://site-overview.com/stats/ehealthglobal.com
Ehealth Global is cloud based telemedicine software providing e-prescribing, pharmacy software systems, retail pharmacy software, remote medical access, and private virtual clinics.
  • Google+ Identity: +Ehealthglobal
  • Google Analytics ID: 62630510-5
  • Website Address renewal date: 17/8/12
  • Domain Address Reg. date: 05/4/12
  • Website address in use until: 18/4/12
Alpha-1 Proteinase Inhibitor | Zemaira
http://site-overview.com/stats/zemaira.com
Learn about living with alpha-1 antitrypsin deficiency and Zemaira therapy. See full safety and prescribing information.
  • Google Analytics ID: 418440-13
  • Website Address renewal date: 16/9/14
  • Domain Address Reg. date: 01/10/16
  • Website address in use until: 18/10/16
INGREZZA® (valbenazine) for adults with tardive dyskinesia (TD)
http://site-overview.com/stats/ingrezza.com
Learn more about INGREZZA—the first FDA-approved treatment for adults with tardive dyskinesia (TD).
  • Google Analytics ID: 76386630-3
  • Website Address renewal date: 17/10/15
  • Domain Address Reg. date: 15/12/14
  • Website address in use until: 18/12/14
Moderate to severe plaque psoriasis treatment | TREMFYA™ (guselkumab)
http://site-overview.com/stats/tremfya.com
Learn about TREMFYA™ (guselkumab), which is approved for adult patients with moderate to severe plaque psoriasis. See full Prescribing Info & Important Safety Info
  • Google Analytics ID: 70816641-32
  • Website Address renewal date: 17/10/9
  • Domain Address Reg. date: 16/2/19
  • Website address in use until: 19/2/19
INGREZZA® (valbenazine) for adults with tardive dyskinesia (TD) | HCP Website
http://site-overview.com/stats/ingrezzahcp.com
Get information on INGREZZA safety, dosing, and efficacy to help support your adult patients with TD. See safety and product information.
  • Google Analytics ID: 76386630-4
  • Website Address renewal date: 17/9/12
  • Domain Address Reg. date: 17/9/12
  • Website address in use until: 19/9/12
SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII)
http://site-overview.com/stats/suboxone.com
SUBOXONE Film along with counseling and psychosocial support may help you—or someone you care about—manage opioid dependence. See full safety and prescribing information.
  • Google Analytics ID: 32458541-1
  • Website Address renewal date: 17/3/28
  • Domain Address Reg. date: 99/4/1
  • Website address in use until: 18/4/1
Factor VIII Therapy for Hemophilia A | AFSTYLA Antihemophilic Factor (Recombinant), Single Chain
http://site-overview.com/stats/afstyla.com
Learn about AFSTYLA, a Factor VIII therapy that provides long-lasting bleed protection for people with hemophilia A. Also explore how to get a free 30-day trial.
  • Google Analytics ID: 7437520-74
  • Website Address renewal date: 17/2/9
  • Domain Address Reg. date: 15/3/12
  • Website address in use until: 19/3/12
INVOKANA® (canagliflozin) Treatment | HCP
http://site-overview.com/stats/invokanahcp.com
Learn more about a once-daily treatment option that can help lower blood glucose in adults. See full Prescribing and safety info.
  • Google Analytics ID: 70816641-5
  • Website Address renewal date: 17/5/12
  • Domain Address Reg. date: 12/8/14
  • Website address in use until: 17/8/14
EDARBI (azilsartan medoxomil) & EDARBYCLOR (azilsartan medoxomil/chlorthalidone) Tablets
http://site-overview.com/stats/edarbi.com
EDARBI & EDARBYCLOR are prescription medicines used to treat high blood pressure (hypertension)… See important safety info & prescribing info, including boxed WARNING.
  • Website Address renewal date: 17/2/22
  • Domain Address Reg. date: 09/7/28
  • Website address in use until: 21/11/2
Opioid Prescribing Recommendations for Surgery
http://site-overview.com/stats/opioidprescribing.info
  • Google Analytics ID: 108247433-1
  • Website Address renewal date: 17/10/21
  • Domain Address Reg. date: 17/8/22
  • Website address in use until: 18/8/22
EMVERM (mebendazole) | 100-mg Chewable Tablet and Pinworm Treatment
http://site-overview.com/stats/emverm.com
EMVERM (mebendazole) 100-mg chewable tablets are a pinworm treatment. Learn more about EMVERM. Only your doctor can determine if EMVERM is right for you.
  • Google Analytics ID: 73325228-3
  • Website Address renewal date: 17/3/17
  • Domain Address Reg. date: 14/4/21
  • Website address in use until: 18/4/21
REXULTI® (brexpiprazole) | Depression Medication
http://site-overview.com/stats/rexulti.com
REXULTI is an add-on treatment for adults with major depressive disorder. See Important Safety Information and Full Prescribing Information, including Boxed WARNING.
  • Website Address renewal date: 16/4/8
  • Domain Address Reg. date: 11/10/5
  • Website address in use until: 21/10/5
Safe and Effective Opioid Prescribing for Chronic Pain
http://site-overview.com/stats/opioidprescribing.com
  • Google Analytics ID: 17849414-1
  • Website Address renewal date: 16/10/6
  • Domain Address Reg. date: 10/10/5
  • Website address in use until: 17/10/5
DEXILANT (dexlansoprazole) for U.S. Healthcare Professionals
http://site-overview.com/stats/dexilanthcp.com
Find DEXILANT (dexlansoprazole) dosing information, clinical data, safety data, and Instant Savings Card information. See Important Safety Information and Prescribing Information.
  • Google Analytics ID: 29097032-1
  • Website Address renewal date: 17/2/22
  • Domain Address Reg. date: 11/6/29
  • Website address in use until: 18/6/29
GLP-1 RA Therapy for T2D | Ozempic® (semaglutide) injection 0.5 mg or 1 mg
http://site-overview.com/stats/ozempicpro.com
Once weekly Ozempic® for Type 2 diabetes is now available in pharmacies. See Full Prescribing and Safety Information including Boxed Warning.
  • Website Address renewal date: 17/9/22
  • Domain Address Reg. date: 16/10/3
  • Website address in use until: 18/10/3
Fiasp® Fast-Acting Insulin | Fiasp® (insulin aspart injection) 100 U/mL
http://site-overview.com/stats/fiasppro.com
Fiasp® is a fast-acting insulin aspart indicated to improve glycemic control in adults with type 1 or type 2 diabetes. Read important safety & prescribing info on this page.
  • Known AddThis user account: ra-57d08e7d95e26a45
  • Google Analytics ID: 44074826-94
  • Website Address renewal date: 16/12/20
  • Domain Address Reg. date: 16/12/20
  • Website address in use until: 18/12/20
XARELTO® (rivaroxaban) | Prescription Blood Thinner
http://site-overview.com/stats/drive4clots.com
Learn about prescription blood thinner XARELTO® including treatment information and cost. See Full Prescribing & Safety Info including Boxed Warnings.
  • Google Analytics ID: 70816641-13
  • Website Address renewal date: 16/12/15
  • Domain Address Reg. date: 15/1/15
  • Website address in use until: 18/1/15
Vraylar® (cariprazine) Bipolar I Disorder & Schizophrenia Treatment
http://site-overview.com/stats/vraylar.com
Learn about Vraylar (cariprazine) for acute manic/mixed episodes of Bipolar I disorder & schizophrenia in adults. See risk info, including Boxed Warning & full Prescribing Information.
  • Website Address renewal date: 17/3/23
  • Domain Address Reg. date: 11/3/22
  • Website address in use until: 19/3/22
XARELTO® (rivaroxaban) | Prescription Blood Thinner
http://site-overview.com/stats/xarelto-us.com
Learn about prescription blood thinner XARELTO® including treatment information and cost. See Full Prescribing & Safety Info including Boxed Warnings.
  • Google Analytics ID: 70816641-13
  • Website Address renewal date: 17/3/12
  • Domain Address Reg. date: 09/3/16
  • Website address in use until: 19/3/16
Schizophrenia Medication & Treatment Info | ARISTADA® (aripiprazole lauroxil)
http://site-overview.com/stats/aristadahcp.com
Please see Important Safety Information and full Prescribing Information, including Boxed Warning, and Medication Guide.
  • Google Analytics ID: 66337106-1
  • Website Address renewal date: 17/2/3
  • Domain Address Reg. date: 16/4/4
  • Website address in use until: 20/4/4
HIV-1 Treatment l Atripla® (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
http://site-overview.com/stats/atripla.com
Learn about ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) an HIV-1 treatment. See Safety Info including Boxed WARNING and Full Prescribing Info.
  • Website Address renewal date: 17/3/2
  • Domain Address Reg. date: 05/3/29
  • Website address in use until: 18/3/29
INVEGA TRINZA® (paliperidone palmitate) | Homepage
http://site-overview.com/stats/invegatrinza.com
Learn about INVEGA TRINZA® including condition and treatment information. See full Prescribing and Important Safety Information including Boxed Warning.
  • Google Analytics ID: 614896-47
  • Website Address renewal date: 17/9/16
  • Domain Address Reg. date: 14/10/17
  • Website address in use until: 18/10/17
KALETRA® (Iopinavir/ritonavir)
http://site-overview.com/stats/kaletra.com
Learn about KALETRA® (Iopinavir/ritonavir). Official site from AbbVie Inc. Includes safety and prescribing information.
  • Website Address renewal date: 17/3/19
  • Domain Address Reg. date: 00/4/20
  • Website address in use until: 18/4/20
Lifestyle Medicine Global Alliance - Global Vision of True Health Care | A world free of non-communicable disease.
http://site-overview.com/stats/lifestylemedicineglobal.org
Creating a New, Global Vision of True Health Care for the 21st Century Medical Professionals Prescribing Lifestyle for Prevention, Treatment and Reversal.
  • Google Analytics ID: 85986528-1
  • Website Address renewal date: 17/12/27
  • Domain Address Reg. date: 16/1/25
  • Website address in use until: 19/1/25
Omni Medical Staffing Services – Providing Compassionate MMJ Physicians
http://site-overview.com/stats/omnidoctors.com
Compassionate doctors prescribing alternative pain management solutions! - Omni Medical Marijuana Clinic in Metro Detroit, Michigan and Chicago, Illinois
  • Google Analytics ID: 86232423-1
  • Website Address renewal date: 17/12/14
  • Domain Address Reg. date: 16/12/14
  • Website address in use until: 18/12/14
High LDL-C & A1C Therapy | Welchol® (colesevelam HCI)
http://site-overview.com/stats/welcholhcp.com
Learn about Welchol® a treatment indicated to treat patients with type 2 diabetes by lowering A1C and LDL-C levels. See Safety & Prescribing Information.
  • Website Address renewal date: 16/7/28
  • Domain Address Reg. date: 10/8/12
  • Website address in use until: 19/8/12
Iron Deficiency Anemia Treatment | INJECTAFER® HCP
http://site-overview.com/stats/injectaferhcp.com
Learn about INJECTAFER® (ferric carboxymaltose injection) for patients with iron deficiency anemia. See Full Prescribing & Safety Info.
  • Website Address renewal date: 17/5/31
  • Domain Address Reg. date: 17/5/31
  • Website address in use until: 20/5/31
Chronic Pain Management | MORPHABOND ER™ (morphine sulfate)
http://site-overview.com/stats/morphabondhcp.com
Learn about MORPHABOND ER™ (morphine sulfate), a long-acting opioid indicated for chronic pain. See Full Prescribing & Safety Information, including Boxed Warning.
  • Website Address renewal date: 17/2/10
  • Domain Address Reg. date: 17/2/10
  • Website address in use until: 20/2/10
RightBreathe
http://site-overview.com/stats/rightbreathe.com
Inhaler prescribing information
  • Google Analytics ID: 57580228-10
  • Website Address renewal date: 16/9/29
  • Domain Address Reg. date: 16/6/14
  • Website address in use until: 19/6/14
Schizophrenia Medication & Treatment Info | ARISTADA® (aripiprazole lauroxil)
http://site-overview.com/stats/aristada.com
Please see Important Safety Information and full Prescribing Information, including Boxed Warning, and Medication Guide.
  • Google Analytics ID: 66337106-3
  • Website Address renewal date: 17/7/20
  • Domain Address Reg. date: 12/9/18
  • Website address in use until: 20/9/18
DUPIXENT® (dupilumab) HCP Website
http://site-overview.com/stats/dupixenthcp.com
DUPIXENT® is for your adult patients with uncontrolled moderate-to-severe atopic dermatitis. Learn more now. Please see Prescribing Information and Important Safety Information on website.
  • Website Address renewal date: 16/10/13
  • Domain Address Reg. date: 16/10/13
  • Website address in use until: 18/10/13
Official Healthcare Professional Site | ORENCIA® (abatacept)
http://site-overview.com/stats/orenciahcp.com
Our site offers info for healthcare providers treating patients with moderate to severe rheumatoid arthritis. See Important Safety Info and Prescribing Info.
  • Website Address renewal date: 17/2/26
  • Domain Address Reg. date: 15/3/2
  • Website address in use until: 18/3/2
WKO4 | TrainingPeaks
http://site-overview.com/stats/wko4.com
Using your athlete’s unique physiology, WKO4 will help you identify individual strengths and weaknesses. You’ll gain faster insights and have confidence in prescribing the most precise training possible.
  • Google+ Identity: +trainingpeaks
  • Google Analytics ID: 42726244-2
  • Website Address renewal date: 17/12/4
  • Domain Address Reg. date: 12/12/3
  • Website address in use until: 18/12/3
MAVYRET (glecaprevir/pibrentasvir)
http://site-overview.com/stats/mavyret.com
Official Site from AbbVie Inc. for patients. View Prescribing Information to learn about the uses, benefits and risks of MAVYRET.
  • Website Address renewal date: 17/7/10
  • Domain Address Reg. date: 17/3/7
  • Website address in use until: 18/3/7
VONVENDI® [von Willebrand factor (Recombinant)] Official Website: For Adults with von Willebrand disease (VWD)
http://site-overview.com/stats/vonvendi.com
Learn about VONVENDI for adults with VWD. Please see Detailed Important Risk Information and full Prescribing Information.
  • Website Address renewal date: 18/2/2
  • Domain Address Reg. date: 15/2/6
  • Website address in use until: 19/2/6
Synthroid® (levothyroxine sodium tablets, USP) | Official Website
http://site-overview.com/stats/synthroid.com
Learn about Synthroid® (levothyroxine sodium tablets, USP) and click for full safety and prescribing information, including important safety information.
  • Website Address renewal date: 17/2/17
  • Domain Address Reg. date: 96/12/2
  • Website address in use until: 17/12/1
Patient Web site for AMRIX® (Cyclobenzaprine Hydrochloride Extended‐Release Capsules)
http://site-overview.com/stats/amrix.com
Learn about AMRIX® (Cyclobenzaprine Hydrochloride Extended‐Release Capsules) for the treatment of muscle spasm due to acute, painful musculoskeletal conditions. AMRIX is a prescription medicine used along with rest and physical therapy to help treat muscle spasm due to acute, painful musculoskeletal problems. AMRIX should only be used for up to 2 or 3 weeks. It is not known if AMRIX is effective when used for longer periods. It is not known if AMRIX is safe and effective in children. Do not take AMRIX if you: • are allergic to cyclobenzaprine or any of the components of AMRIX. Talk to your healthcare provider or get medical help right away if you have symptoms of an allergic reaction such as difficulty breathing, hives, swelling of your face or tongue, or itching • are taking certain antidepressants known as monoamine oxidase (MAO) inhibitors, or it has been 14 days or less since you stopped taking a MAO inhibitor. Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure • have had a recent heart attack • have heart rhythm problems (arrhythmias) • have heart failure • have an overactive thyroid (hyperthyroidism). Talk to your healthcare provider before taking this medicine if you have any of the conditions listed above. You should not drink alcohol until you know how AMRIX affects you. Taking AMRIX with alcohol or other medicines that depress your central nervous system can slow your thinking and physical response times. Do not drive, operate machinery, or do other dangerous activities until you know how AMRIX affects you. AMRIX may cause serious side effects that may lead to heart attack or stroke. Call your healthcare provider immediately or go to the nearest hospital emergency room if you have: • irregular or abnormal heartbeats (arrhythmias) • fast heartbeat (tachycardia). Serotonin syndrome is a serious medical condition that may happen when AMRIX is taken with certain other medicines. Call your healthcare provider right away or go to the nearest hospital emergency room if you become severely ill and have some or all of these symptoms: • agitation, hallucinations, coma, or other changes in mental status • coordination problems or muscle twitching (overactive reflexes) • fast heartbeat, high or low blood pressure • sweating or fever • nausea, vomiting, or diarrhea • muscle stiffness or tightness. The most common side effects of AMRIX include dry mouth, dizziness, fatigue, constipation, nausea, upset stomach, and drowsiness. Tell your healthcare provider if you get any side effect that bothers you or that does not go away. These are not all the possible side effects of AMRIX. For more information, talk to your healthcare provider or pharmacist. Please see the Patient Information Leaflet within the accompanying Full Prescribing Information.
  • Google Analytics ID: 38345010-1
  • Website Address renewal date: 16/11/15
  • Domain Address Reg. date: 01/11/20
  • Website address in use until: 17/11/20
VYXEOS™ (daunorubicin and cytarabine) liposome for injection
http://site-overview.com/stats/vyxeos.com
See full Prescribing Information including BOXED Warning. Healthcare professional information about VYXEOS™ (daunorubicin and cytarabine).
  • Website Address renewal date: 17/5/5
  • Domain Address Reg. date: 14/8/11
  • Website address in use until: 18/8/11
VALSTAR® (valrubicin) Official Patient Site
http://site-overview.com/stats/valstarsolution.com
Learn about VALSTAR® (valrubicin), including safety and side effects, features and risks, and full prescribing information
  • Google Analytics ID: 43422492-9
  • Website Address renewal date: 18/3/2
  • Domain Address Reg. date: 07/3/6
  • Website address in use until: 19/3/6
2024-05-13 23:29:44 ... 0.0705